Effects of high-voltage long-term pulsed radiofrequency therapy for cervicogenic headache on elastic value of suboccipital muscle groups and vertebral artery blood flow

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400085733

Enrollment

Unknown

Registered

2024-06-17

Start date

2023-10-21

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervicogenic headache

Interventions

Group A:Low-temperature plasma radiofrequency ablation therapy

Group B:High voltage long-term pulse radiofrequency therapy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The course of the disease = 3 months; (2) CT or MRI confirmed that cervical disc degeneration, intervertebral disc bulge, spinal canal and lateral crypt have no obvious stenosis; (3) meet the diagnostic criteria of the International Classification of Headache Disorders (3rd edition, ICHD-3); (4) Exclude diseases with similar clinical characteristics such as migraine, tension headache and cluster headache (sphenopalatine neuralgia). (5) the patient has moderate or severe pain most of the time; (6) The effect of conservative treatment such as physical therapy and oral drugs is not good. (7) Voluntarily participate and sign informed consent

Exclusion criteria

Exclusion criteria: ? Postoperative or cervical spine deformity; ? Severe cervical disc herniation, intervertebral disc prolapse or detachment, vertebral spondylolisthesis, and spinal instability; ? Recently, there has been a sharp decline in limb muscle strength; ? CT/MRI confirmed clear vertebral canal or intracranial space occupying changes; ? Merge diseases that seriously affect patient pain perception and severe pathological neuropathy; ? Local infection or combined systemic infection at the puncture site; ? Combined with blood diseases or coagulation disorders; ? Unable to cooperate with operators due to concomitant mental nervous system diseases; ? Individuals with severe heart and lung disease or liver and kidney dysfunction (ASA grade>III) or other individuals who are not suitable for minimally invasive surgical treatment. ? Disagree with randomized treatment plan

Design outcomes

Primary

Measure	Time frame
Muscle elasticity value;	—

Secondary

Measure	Time frame
V3 vertebral artery blood flow;NRS;Dizziness symptoms;	—

Countries

China

Contacts

Public Contactbaishan wu

Xuanwu Hospital, Capital Medical University

937055079@qq.com+86 139 1015 0148

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026